Search Results
Jul 31, 2025, 17:15 ET RAMACO RESOURCES REPORTS SECOND QUARTER 2025 RESULTS
2027 versus 2028 previously.The results of the Summary PEA outline NPV8 (net present value using an 8% discount rate) of $1.197 billion and NPV10 (net present value using a 10% discount rate) of $898 million (pre-tax)
More news about: Ramaco Resources, Inc.
Jul 31, 2025, 06:30 ET Thesis Gold Announces Board and Management Changes
District. The recently completed Preliminary Economic Assessment (PEA) highlights robust project economics, including a 35.2% after-tax IRR and an after-tax NPV5% of C$1.28 billion, demonstrating the potential for significant value creation. The Company's 2025 roadmap includes a
More news about: Thesis Gold Inc.
Jul 29, 2025, 06:00 ET VIZSLA SILVER INCREASES EXPLORATION, COMPLETES GEOPHYSICAL SURVEY HIGHLIGHTING NEW TARGETS PROXIMAL TO PANUCO PROJECT 1 & COMMENCES INITIAL FIELD WORK AT NEWLY ACQUIRED SANTA FÉ PROPERTY TO THE SOUTH OF PANUCO IN THE HUNT FOR PROJECT 2
Panuco in July 2024 which highlights 15.2 Moz AgEq of annual production over an initial 10.6-year mine life, an after-tax NPV5% of US$1.1B, 86% IRR and a 9-month payback at US$26/oz Ag and US$1,975/oz
More news about: Vizsla Silver Corp.
Jul 23, 2025, 09:00 ET Total Economic Impact Study Shows 321% ROI for Organizations Deploying Flare
representative of interviewed customers with experience deploying Flare saw a 321% return on investment (ROI) over three years, with a net present value (NPV) of $699,000, and a payback period under six months.
More news about: Flare
Jul 22, 2025, 03:00 ET SkylineDx's Merlin Melanoma Assay shows its ability to reduce SLNB by over 40% in a Danish Multicenter Validation Study
risk. Key findings of the study include: The potential SLNB reduction rate was highest for the pT1-subgroup at 72.7% (NPV 94.5%) In pT1-pT3 melanoma, 41% of patients were classified as CP-GEP Low-Risk and could have forgone SLNB surgery, which is in line with previous validation
More news about: SkylineDx
Jul 21, 2025, 17:00 ET New Found Gold Announces Preliminary Economic Assessment for the Queensway Gold Project
after-tax NPV5% of $743 million and an IRR of 56.3%. Growth Capital of $442M for Phase 2 is spent in Year 2 to Year 4 and is paid back in Year 5, less than one year after Phase 2 is in operation. The after-tax NPV5% increases
More news about: New Found Gold Corp.
Jul 21, 2025, 08:30 ET CENTURY LITHIUM REPORTS BATTERY-GRADE LITHIUM METAL ANODES PRODUCED FROM ANGEL ISLAND LITHIUM CARBONATE
expected project economics for the Project, such as estimates of life of mine, lithium prices, production and recoveries, capital and operating costs, IRR, NPV and cash flows, any projections outlined in the Feasibility Study in respect of the Project, the permitting status of the Project and the Company's future
More news about: Century Lithium Corp.
Jul 17, 2025, 18:45 ET Human Longevity, Inc. Expands $1 Million Cancer Prevention Pledge to Safeguard Against Late-Stage Ovarian Cancer
Ovarian Cancer Liquid Biopsy — the first clinically validated blood test to detect early-stage ovarian cancer with high negative predictive value (NPV). By identifying tumor-derived cell-free DNA signals, the Avantect® test enhances HLI's multi-modal detection strategy. This precision
More news about: Human Longevity, Inc.
Jul 16, 2025, 06:30 ET Denison Announces Discovery of Additional High-Grade Mineralization at Gryphon and Reports Results from Successful Delineation Program
with a cost update completed in 2023. The outcomes of the study highlight robust economics with an estimated after-tax base-case Net Present Value ("NPV") of $864.2 million and internal rate of return ("IRR") of 37.6%, based on estimated Probable Reserves of 49.7 million
More news about: Denison Mines Corp.
Jul 14, 2025, 09:26 ET VIZSLA SILVER ANNOUNCES CLOSING OF OVER-ALLOTMENT OPTION IN FULL
Panuco in July 2024 which highlights 15.2 Moz AgEq of annual production over an initial 10.6-year mine life, an after-tax NPV5% of US$1.1B, 86% IRR and a 9-month payback at US$26/oz Ag and US$1,975/oz
More news about: Vizsla Silver Corp.
Jul 09, 2025, 08:24 ET Quest Diagnostics to Offer FDA-Cleared Fujirebio Blood Test for Alzheimer's Disease
demographics, and when applying a dual cut point, the FDA-cleared test demonstrated a positive predictive value (PPV) of 92% and a negative predictive value (NPV) of 97%, with 20% of patients uncertain to have amyloid pathology, thus requiring further testing. Quest will showcase its complete line up of
More news about: Quest Diagnostics
Jul 08, 2025, 08:30 ET CENTURY LITHIUM COMMENDS FIRST PHOSPHATE IN MAKING LFP BATTERY CELLS USING CENTURY LITHIUM MATERIAL
expected project economics for the Project, such as estimates of life of mine, lithium prices, production and recoveries, capital and operating costs, IRR, NPV and cash flows, any projections outlined in the Feasibility Study in respect of the Project, the permitting status of the Project and the Company's future
More news about: Century Lithium Corp.
Jul 08, 2025, 02:00 ET Independent Meta-Analysis Shows SkylineDx's Merlin CP-GEP Assay Accurately Stratifies Patients for Sentinel Lymph Node Biopsy Selection
rate of only 5%.Negative Predictive Value and Sentinel Lymph Node Biopsy Reduction Rate were highest for both pT1 and pT2 melanomas (T1: NPV 94%, T2: NPV 95%; T1: RR 72%, T2 RR 31%)."It is really exciting to see that the robust and consistent performance of our Merlin Assay has been
More news about: SkylineDx
Jul 01, 2025, 08:00 ET Independent Preliminary Economic Assessment Report from Fluor Corporation Confirms Commercial and Technical Feasibility of Ramaco's Brook Mine Rare Earth Deposit
on the Company's website.NPV & IRR: The results of the Brook Mine PEA outline NPV8 (net present value using an 8% discount rate) of $1.197 billion and NPV10 (net present value using a 10% discount rate) of $898
More news about: Ramaco Resources, Inc.
Jun 30, 2025, 10:00 ET Independent Study Documents $2.55M in Savings Generated by TransPerfect's GlobalLink Technology
GlobalLink® technology suite delivered a net present value (NPV) of $2.55 million. The study was commissioned by TransPerfect, but Forrester conducted all research independently and maintains
More news about: TransPerfect
Jun 26, 2025, 11:29 ET VIZSLA SILVER CLOSES US$100M BOUGHT DEAL OFFERING
Panuco in July 2024 which highlights 15.2 Moz AgEq of annual production over an initial 10.6-year mine life, an after-tax NPV5% of US$1.1B, 86% IRR and a 9-month payback at US$26/oz Ag and US$1,975/oz
More news about: Vizsla Silver Corp.
Jun 26, 2025, 07:00 ET METALLA PUBLISHES 2025 ASSET HANDBOOK AND ANNUAL LETTER TO SHAREHOLDERS
Metalla has an interest, including without limitation, estimates of mineral resources and mineral reserves and updates thereto, production, mine life, NPV, IRR, costs, drilling, development, permitting, water sourcing, commodity mix and prices, and the timing thereof; future opportunities
More news about: Metalla Royalty & Streaming Ltd.
Jun 23, 2025, 06:41 ET VIZSLA SILVER ANNOUNCES US$100 MILLION BOUGHT DEAL FINANCING
Panuco in July 2024 which highlights 15.2 Moz AgEq of annual production over an initial 10.6-year mine life, an after-tax NPV5% of US$1.1B, 86% IRR and a 9-month payback at US$26/oz Ag and US$1,975/oz
More news about: Vizsla Silver Corp.
Jun 18, 2025, 09:01 ET GRAIL Announces Positive Top-Line Results From The Galleri® PATHFINDER 2 Registrational Study
detected test result, and 2) to evaluate the performance of the Galleri MCED test across various measures, including PPV, negative predictive value (NPV), sensitivity, specificity, and CSO prediction accuracy. Participants who receive a cancer signal detected result undergo additional diagnostic testing
More news about: GRAIL, Inc.
Jun 18, 2025, 08:12 ET VIZSLA SILVER PROVIDES AN UPDATE ON THE COPALA TEST MINE AT ITS PANUCO PROJECT IN MEXICO
Panuco in July 2024 which highlights 15.2 Moz AgEq of annual production over an initial 10.6-year mine life, an after-tax NPV5% of US$1.1B, 86% IRR and a 9-month payback at US$26/oz Ag and US$1,975/oz
More news about: Vizsla Silver Corp.